CEO of Cell Therapeutics Inc. (CTIC, Financial) James A Bianco sells 1,366,108 shares of CTIC on 09/11/2009 at an average price of $1.43 a share.
Cell Therapeutic developing acquiring and commercializing novel treatments for cancer. Our goal is to build a leading vertically-integrated biopharmaceutical company with a diversified portfolio of oncology drugs and drug candidates. The company's research and in-licensing activities are concentrated on identifying new less toxic and more effective ways to treat cancer. The company has received fast-track designation from the FDA for this indication and expect to receive priority review which would expedite the FDA's review of our application. Cell Therapeutics Inc. has a market cap of $768.4 million; its shares were traded at around $1.42 with and P/S ratio of 67.2.
Recent Trades of Cell Therapeutics Inc. by Directors and Officers:
Cell Therapeutic developing acquiring and commercializing novel treatments for cancer. Our goal is to build a leading vertically-integrated biopharmaceutical company with a diversified portfolio of oncology drugs and drug candidates. The company's research and in-licensing activities are concentrated on identifying new less toxic and more effective ways to treat cancer. The company has received fast-track designation from the FDA for this indication and expect to receive priority review which would expedite the FDA's review of our application. Cell Therapeutics Inc. has a market cap of $768.4 million; its shares were traded at around $1.42 with and P/S ratio of 67.2.
Recent Trades of Cell Therapeutics Inc. by Directors and Officers:
- Sell: Director Phillip M Phd Nudelman sold 164,000 shares of CTIC stock on 08/14/2009 at the average price of $1.57; the price of the stock has decreased by 9.55% since.
- Sell: Director Richard L Love sold 70,000 shares of CTIC stock on 08/12/2009 at the average price of $1.64; the price of the stock has decreased by 13.41% since.
- Sell: Director John H Bauer sold 80,000 shares of CTIC stock on 08/10/2009 at the average price of $1.5; the price of the stock has decreased by 5.33% since.
- Sell: Director John H Bauer sold 25,000 more shares of CTIC stock on 06/02/2009 at the average price of $1.76; the price of the stock has decreased by 19.32% since.
